(PhysOrg.com) -- Harvard Stem Cell Institute researcher George Q. Daley, associate director of the Stem Cell Program at Children's Hospital Boston, has with HSCI colleagues Chad Cowan and Konrad Hochedlinger of Massachusetts General Hospital produced a robust new collection of disease-specific stem cell lines, all of which were developed using the new induced pluripotent stem cell (iPS) technique. The work is described in a paper published in today's online edition of the journal Cell.
- Daley and colleagues create 20 disease-specific stem cell linesThu, 7 Aug 2008, 12:37:21 EDT
- Gene silencing may be responsible for induced pluripotent stem cells' limitationsSun, 25 Apr 2010, 13:25:25 EDT
- Researchers generate iPSCs to further treatments for lung diseaseThu, 28 Oct 2010, 10:06:50 EDT
- George Daley to discuss challenges and opportunities facing stem cell scientistsSat, 20 Feb 2010, 15:58:39 EST
- Genetic abnormalities identified in pluripotent stem cell linesThu, 6 Jan 2011, 13:13:48 EST